Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 24, 2022
[Questionnaire Survey on Adoption and Prescription of Biosimilars (Antibody and Its-related Products) by Medical Doctors in Japan]Yoshiko Aoki, Kimie Sai, Yukiko Katsuta, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 3, 2013
[Biomarker exploration and its clinical use]Yoshiro Saito, Kimie Sai, Nahoko Kaniwa, et al.
Biological & Pharmaceutical Bulletin|September 5, 2017
Effect of Infectious Diseases on the Pathogenesis of Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisYoshimi Okamoto-Uchida, Ryosuke Nakamura, Kimie Sai, et al.
Pharmacoepidemiology and Drug Safety|June 1, 2018
Association between dipeptidyl peptidase-4 inhibitors and urinary tract infection in elderly patients: A retrospective cohort studyTakuya Imatoh, Takumi Nishi, Midori Yasui, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Determination of CYP2D6 gene alleles by the CYP450 probe array using the Affymetrix GeneChip system: comparison with sequencing resultsSeiichi Ishida, Akiko Soyama, Yoshiro Saito, et al.
European Journal of Clinical Pharmacology|August 24, 2017
Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report databaseTakuya Imatoh, Kimie Sai, Chisato Fukazawa, et al.
Biological & Pharmaceutical Bulletin|January 3, 2024
Clinical Profiles of Japanese Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Collected by a Nationwide System from 2006 to 2023Eri Tsukagoshi, Ryosuke Nakamura, Nahoko Kaniwa, et al.
Pageof 7